Industry Gets Extra Month For 510(k) Revamp Comments
Executive Summary
The US FDA has extended the comment period on proposed changes to the 510(k) process until May 22, giving stakeholders an extra 30 days. The controversial proposal would publicize devices that used older predicates.
You may also be interested in...
Standards, Not Predicates Emphasized In Finalized Alternative 510(k) Pathway
Despite pushback from industry, US FDA has moved forward with plans to establish a new alternative 510(k) pathway by finalizing a guidance document that describes the so-called “Safety and Performance Based Pathway” that emphasizes use of consensus standards instead of direct predicate comparisons.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
FDA Leader Looks To International Effort On Pediatric Device Development
Collaboration with Japan and Europe could help ease the development path for pediatric devices, cardiovascular device office director Bram Zuckerman said at a recent conference. Zuckerman also spoke on other cardiac device priorities at the FDA.